Ishiguro N - Search Results

1

Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study.

Urakawa H, Ando Y, Hase T, Kikumori T, Arai E, Maeda O, Mitsuma A, Sugishita M, Shimokata T, Ikuta K, Ishiguro N, Nishida Y. Urakawa H, et al. Among authors: ishiguro n. Int J Cancer. 2020 Jun 15;146(12):3504-3515. doi: 10.1002/ijc.32836. Epub 2019 Dec 28. Int J Cancer. 2020. PMID: 31846063

2

The effect of da-fang-feng-tang on treatment of type II collagen-induced arthritis in DBA/1 mice.

Wang LR, Ishiguro N, Yamada E, Nishida Y, Sato K, Iwata H. Wang LR, et al. Among authors: ishiguro n. Am J Chin Med. 1999;27(2):205-15. doi: 10.1142/S0192415X99000240. Am J Chin Med. 1999. PMID: 10467454

3

Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells.

Kurokouchi K, Kambe F, Kikumori T, Sakai T, Sarkar D, Ishiguro N, Iwata H, Seo H. Kurokouchi K, et al. Among authors: ishiguro n. J Bone Miner Res. 2000 Sep;15(9):1707-15. doi: 10.1359/jbmr.2000.15.9.1707. J Bone Miner Res. 2000. PMID: 10976991 Free article.

4

Telomerase, p53 and PCNA activity in osteosarcoma.

Nakashima H, Nishida Y, Sugiura H, Katagiri H, Yonekawa M, Yamada Y, Iwata H, Nagasaka T, Ishiguro N. Nakashima H, et al. Among authors: ishiguro n. Eur J Surg Oncol. 2003 Sep;29(7):564-7. doi: 10.1016/s0748-7983(03)00117-3. Eur J Surg Oncol. 2003. PMID: 12943619

5

Stimulated type I collagen turnover in patients with giant cell tumor of bone.

Nakashima H, Sugiura H, Nishida Y, Yamada Y, Tabata I, Ishiguro N. Nakashima H, et al. Among authors: ishiguro n. Calcif Tissue Int. 2003 Jul;73(1):5-8. doi: 10.1007/s00223-002-1060-3. Calcif Tissue Int. 2003. PMID: 14506947

6

A study of inter-alpha-trypsin inhibitor chains expression in liposarcomas.

Tabata I, Nishida Y, Sugiura H, Zhuo L, Yoneda M, Kimata K, Nakashima H, Ishiguro N. Tabata I, et al. Among authors: ishiguro n. Eur J Surg Oncol. 2003 Oct;29(8):665-9. doi: 10.1016/s0748-7983(03)00135-5. Eur J Surg Oncol. 2003. PMID: 14511615

7

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction.

Uchibori M, Nishida Y, Tabata I, Sugiura H, Nakashima H, Yamada Y, Ishiguro N. Uchibori M, et al. Among authors: ishiguro n. J Rheumatol. 2004 Jan;31(1):110-9. J Rheumatol. 2004. PMID: 14705229

8

Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.

Nishida Y, Knudson W, Knudson CB, Ishiguro N. Nishida Y, et al. Among authors: ishiguro n. Exp Cell Res. 2005 Jul 1;307(1):194-203. doi: 10.1016/j.yexcr.2005.03.026. Epub 2005 Apr 21. Exp Cell Res. 2005. PMID: 15922739 Free PMC article.

9

Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.

Naruse T, Nishida Y, Hosono K, Ishiguro N. Naruse T, et al. Among authors: ishiguro n. Carcinogenesis. 2006 Mar;27(3):584-92. doi: 10.1093/carcin/bgi240. Epub 2005 Oct 11. Carcinogenesis. 2006. PMID: 16219634

10

Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.

Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N. Uchibori M, et al. Among authors: ishiguro n. Int J Oncol. 2006 Jan;28(1):33-42. Int J Oncol. 2006. PMID: 16327977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,312 results

Search Page

Filters